Applied DNA Sciences Inc (NAS:APDN)
$ 3.74 0.005 (0.13%) Market Cap: 3.23 Mil Enterprise Value: 982,000.00 PE Ratio: 0 PB Ratio: 0.61 GF Score: 50/100

Q4 2022 Applied DNA Sciences Inc Earnings Call Transcript

Dec 14, 2022 / 09:30PM GMT
Release Date Price: $28 (-4.76%)
Operator

Good afternoon, and welcome to the Applied DNA Sciences Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Sanjay Hurry, Investor Relations for Applied DNA. Please go ahead.

Sanjay M. Hurry
Applied DNA Sciences, Inc. - Executive Director of IR & Corporate Communications

Thank you, Gary. Good afternoon, everyone, and welcome to Applied DNA's conference call to discuss our fourth quarter and fiscal year 2022 financial results. You can access the press release that was issued after market closed today, as well as the slide presentation accompanying this call on the Investor Relations section of our corporate website.

Speaking on the call today are Dr. James Hayward, our Chairman, President and CEO; and Beth Jantzen, our CFO. Judy Murrah, our COO; and Clay Shorrock, our Chief Legal Officer and Head of Business Development, will also be available to answer questions on the Q&A portion of the call.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot